OTCMKTS:HLUYY

H. Lundbeck A/S (HLUYY) Stock Price, News & Analysis

H. Lundbeck A/S logo
$22.00 -0.01 (-0.02%)
As of 08/9/2022

About H. Lundbeck A/S Stock (OTCMKTS:HLUYY)

Key Stats

Today's Range
$22.00
▼
$24.00
50-Day Range
$22.00
▼
$22.00
52-Week Range
$10.00
▼
$31.55
Volume
7,500 shs
Average Volume
1,758 shs
Market Capitalization
$21.91 billion
P/E Ratio
25.00
Dividend Yield
0.91%
Price Target
N/A
Consensus Rating
N/A

Company Overview

H. Lundbeck A/S is a Danish pharmaceutical company focused on developing and commercializing treatments for brain diseases. Its work spans research, development, manufacturing and distribution of medicines for neurological and psychiatric conditions.

The company’s portfolio includes treatments for conditions such as depression, schizophrenia, migraine, epilepsy and Parkinson’s disease. Products include Vyepti, a preventive migraine treatment, and Rexulti, used for certain psychiatric conditions; product availability and approved uses vary by country.

Founded in 1915, Lundbeck is headquartered in Copenhagen, Denmark, and serves patients in markets around the world through its own operations and commercial partnerships. Charl van Zyl became the company’s president and chief executive officer in 2023.

AI Generated. May Contain Errors.

Receive HLUYY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for H. Lundbeck A/S and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HLUYY Stock News Headlines

H. Lundbeck A/S (OTCMKTS:HLUYY) Trading at $22.00
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
H LUNDBECK A/S A
H LUNDBECK A/S B
H. Lundbeck A/SEO-Medium-Term Nts 2025(25/29) Bond
See More Headlines

HLUYY Stock Analysis - Frequently Asked Questions

H. Lundbeck A/S's stock was trading at $22.00 on January 1st, 2026. Since then, HLUYY shares have increased by 0.0% and is now trading at $22.00.

H. Lundbeck A/S (OTCMKTS:HLUYY) issued its quarterly earnings data on Wednesday, November, 4th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.01 by $0.16. The firm earned $547.05 million during the quarter, compared to analysts' expectations of $514.82 million. H. Lundbeck A/S had a net margin of 6.74% and a trailing twelve-month return on equity of 13.74%.

H. Lundbeck A/S subsidiaries include Alder BioPharmaceuticals, and Prexton Therapeutics.

Based on aggregate information from My MarketBeat watchlists, some other companies that H. Lundbeck A/S investors own include Ionis Pharmaceuticals (IONS), DENTSPLY SIRONA (XRAY), Qiagen (QGEN), Ambu A/S (AMBBY), AFR.L (AFR), Airbnb (ABNB).

Company Calendar

Today
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:HLUYY
CIK
N/A
Employees
5,348
Year Founded
1915

Profitability

EPS (Trailing Twelve Months)
$0.88
Trailing P/E Ratio
25.00
Forward P/E Ratio
7.72
P/E Growth
N/A
Net Income
$209.69 million
Net Margins
6.74%
Pretax Margin
7.83%
Return on Equity
13.74%
Return on Assets
7.16%

Debt

Debt-to-Equity Ratio
0.32
Current Ratio
1.15
Quick Ratio
0.71

Sales & Book Value

Annual Sales
$2.59 billion
Price / Sales
8.45
Cash Flow
$3.36 per share
Price / Cash Flow
6.54
Book Value
$14.60 per share
Price / Book
1.51

Miscellaneous

Outstanding Shares
995,741,000
Free Float
N/A
Market Cap
$21.91 billion
Optionable
Not Optionable
Beta
0.68

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:HLUYY) was last updated on 8/9/2022 by MarketBeat.com Staff.
From Our Partners